ArticleInternal medicine (Tokyo, Japan)2026
Tumor Inflammation-associated Neurotoxicity Following CD19-targeted Chimeric Antigen Receptor T-cell Therapy in a Patient with High-grade B-cell Lymphoma.
Kenjiro Hino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.